NCT06780670
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06780670
Title Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy (PSMAcTION)
Acronym PSMAcTION
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | CHE | BRA | AUS

Facility Status City State Zip Country Details
VA Greater LA Healthcare System RECRUITING Los Angeles California 90073 United States Details
Stanford University Medical Center RECRUITING Palo Alto California 94304 United States Details
University Cancer and Blood Center LLC RECRUITING Athens Georgia 30607 United States Details
Indiana University RECRUITING Indianapolis Indiana 46202 United States Details
University of Kansas Hospital RECRUITING Kansas City Kansas 66160 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
WA Uni School Of Med RECRUITING St Louis Missouri 63110 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68154 United States Details
New Jersey Urology LLC RECRUITING Voorhees Township New Jersey 08043 United States Details
Associated Med Professionals of NY RECRUITING Syracuse New York 13210 United States Details
Montefiore Medical Center RECRUITING The Bronx New York 10467 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Urology San Antonio RECRUITING San Antonio Texas 78229 United States Details
Medical College Of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site RECRUITING Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site RECRUITING Herston Queensland 4029 Australia Details
Novartis Investigative Site RECRUITING São Paulo São Paulo 01308-050 Brazil Details
Novartis Investigative Site RECRUITING São Paulo São Paulo 05652-000 Brazil Details
Novartis Investigative Site RECRUITING Fuzhou Fujian 350025 China Details
Novartis Investigative Site RECRUITING Wuhan Hubei 430022 China Details
Novartis Investigative Site RECRUITING Wuhan Hubei 430030 China Details
Novartis Investigative Site RECRUITING Nanjing Jiangsu 210006 China Details
Novartis Investigative Site RECRUITING Nanjing Jiangsu 210029 China Details
Novartis Investigative Site RECRUITING Shenyang Liaoning 110011 China Details
Novartis Investigative Site RECRUITING Xian Shanxi 710032 China Details
Novartis Investigative Site RECRUITING Xian Shanxi 710061 China Details
Novartis Investigative Site RECRUITING Chengdu Sichuan 610041 China Details
Novartis Investigative Site RECRUITING Beijing 100034 China Details
Novartis Investigative Site RECRUITING Beijing 100036 China Details
Novartis Investigative Site RECRUITING Guangzhou 510060 China Details
Novartis Investigative Site RECRUITING Shanghai 200025 China Details
Novartis Investigative Site RECRUITING Shanghai 200032 China Details
Novartis Investigative Site RECRUITING Tianjin 300300 China Details
Novartis Investigative Site RECRUITING Hong Kong 999077 Hong Kong Details
Novartis Investigative Site RECRUITING Beersheba 8457108 Israel Details
Novartis Investigative Site RECRUITING Haifa 3109601 Israel Details
Novartis Investigative Site RECRUITING Petah Tikva 4941492 Israel Details
Novartis Investigative Site RECRUITING Ramat Gan 5265601 Israel Details
Novartis Investigative Site RECRUITING Tel Aviv 6423906 Israel Details
Novartis Investigative Site RECRUITING Kashiwa Chiba 277-8577 Japan Details
Novartis Investigative Site RECRUITING Sapporo Hokkaido 060-8648 Japan Details
Novartis Investigative Site RECRUITING Kobe Hyōgo 6500047 Japan Details
Novartis Investigative Site RECRUITING Yokohama Kanagawa-ku 236-0004 Japan Details
Novartis Investigative Site RECRUITING Chiba 260-8717 Japan Details
Novartis Investigative Site RECRUITING Fukuoka 812-0033 Japan Details
Novartis Investigative Site RECRUITING Fukuoka 8128582 Japan Details
Novartis Investigative Site RECRUITING Fukushima 9601295 Japan Details
Novartis Investigative Site RECRUITING Ishikawa 9208641 Japan Details
Novartis Investigative Site RECRUITING Kyoto 6068507 Japan Details
Novartis Investigative Site RECRUITING Singapore 119228 Singapore Details
Novartis Investigative Site RECRUITING Singapore 168583 Singapore Details
Novartis Investigative Site RECRUITING Singapore 258499 Singapore Details
Novartis Investigative Site RECRUITING Seoul 03080 South Korea Details
Novartis Investigative Site RECRUITING Seoul 03722 South Korea Details
Novartis Investigative Site RECRUITING Seoul 05505 South Korea Details
Novartis Investigative Site RECRUITING Basel 4031 Switzerland Details
Novartis Investigative Site RECRUITING Bern 3010 Switzerland Details
Novartis Investigative Site RECRUITING Taipei 10002 Taiwan Details
Novartis Investigative Site RECRUITING Taipei 103616 Taiwan Details
Novartis Investigative Site RECRUITING Taipei 11217 Taiwan Details
Novartis Investigative Site RECRUITING Taoyuan District 33305 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field